About IXICO

IXICO has been working since 2004 to help advance therapies for neurological diseases

Background

IXICO is a leading neuroimaging provider helping biopharmaceutical companies maximize the value of their drug development pipelines by transforming data into clinically meaningful insights. Bringing together world-class therapeutic expertise, breakthrough analytics and operational excellence, IXICO is the proven partner of choice for imaging biomarker solutions in CNS clinical trials.

Our solutions are powering some of the most important clinical trials in neuroscience today. Our mission is to transform the advancement of investigational therapies for neurological diseases by bringing safe and effective treatment to patients sooner.

Download Brochure

IXICO's timeline

2004

IXICO founded

A spin-out from London universities' ‘Information eXtraction from Images’ project.

2006

Clinical trial platform launched

IXICO provides neuroscience expertise and global operations to deliver imaging and digital biomarker analytical services for clinical development, within a framework of regulatory compliance.

2007

First Phase 3 trial

IXICO is awarded it's first Phase 3 study for Alzheimer's disease.

2008

Web-based TrialTracker platform launched

The TrialTracker^TM data managment platform is a secure and compliant environment for the collection, analysis and interpretation of large image files and other data that may be generated in the course of a clinical study.

2013

AIM listing

IXICO was listed on the Alternative Investment Market (AIM), a sub-market of the London Stock Exchange (LSE).

2014

Assessa platform launched

The clinical decision support platform, Assessa provides access to expert neuroradiologists for a standardized radiological read, and securely captures then transfers clinical data and MR images from referring neurologists to expert neuroradiologists.

2015

Post-marketing surveillance commercial collaboration

IXICO are partnering with pharma companies to develop digital clinical decision support technologies based on our Assessa platform technology to improve the targeting and the safety and effectiveness of their therapeutics.

2017

Digital biomarkers commercial collaboration

The arrival of connected digital technologies (wearable biosensors and mobile devices) that enable the passive measurement of parameters such as sleep, activity and heart rate outside of the clinic, has provided the opportunity to revolutionize the capture of data in clinical trials.

2018

Product Investment

Oversubscribed placing of £5.5m to invest in new product and new market development

2019

King's College Partnership

IXICO was chosen as partner for King's College London's UK Government-funded Medical Imaging & Artificial Intelligence Centre

Public & Private Partnerships

Innovation is one of our core values, and collaboration is key to advancing treatments for neurological diseases. Working with partners in academia, business and charitable organisations, we help further the international scientific and regulatory agenda and provide access to our platform and advanced data analysis for innovative research.

Work with us

Careers at IXICO

IXICO is a fast-growing data analytics company based in London, UK, working with biopharmaceutical clients, academic partners and clinical research sites around the world.

Specializing in supporting clinical research in neuroscience, we are a passionate and dedicated team of scientists, researchers, quality professionals, and business people, bringing together the essential skills required to innovate and develop and deliver cutting-edge technologies to support our clients' clinical research needs.

View our vacancies